Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/2012
01/10/2012CA2576110C Polypeptides of botryosphaeria rhodina
01/10/2012CA2533332C Therapeutic compounds
01/10/2012CA2455189C Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
01/10/2012CA2453103C Biochip and the production method thereof
01/10/2012CA2444918C Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules
01/10/2012CA2441603C Apparatus and method for sequencing a nucleic acid
01/10/2012CA2436665C Nucleic acid derivatives
01/10/2012CA2428073C Paramyxovirus vector for gene transfer to the cardiovascular system
01/10/2012CA2419541C Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
01/10/2012CA2416963C Methods and compositions for amplification of rna sequences
01/10/2012CA2404488C Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
01/10/2012CA2400295C Modified factor viii
01/10/2012CA2392071C Microparticle-based transfection and activation of dendritic cells
01/10/2012CA2366314C Protein d from haemophilus influenzae as a carrier protein in combination vaccines
01/10/2012CA2356594C Method of breeding yeast
01/10/2012CA2345381C Fluorescent probes for chromosomal painting
01/10/2012CA2292782C Plastid promoters for transgene expression in the plastids of higher plants
01/10/2012CA2262411C Resistance against nematodes and/or aphids
01/10/2012CA2247922C Genetic sequences encoding flavonoid pathway enzymes and uses therefor
01/10/2012CA2222328C Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
01/10/2012CA2221342C A method and nucleotide sequence for transforming microorganisms
01/10/2012CA2214102C Group o hiv-1, fragments of such viruses, and uses thereof
01/07/2012CA2745258A1 Clonal pre-amplification in emulsion
01/05/2012WO2012003493A2 Protein kinase ck2 gene mutations, amplifications and polymorphisms in human cancers and methods of use
01/05/2012WO2012003398A1 Method for uses of protein precursors as prodrugs
01/05/2012WO2012003320A2 Flavivirus host-range mutations and uses thereof
01/05/2012WO2012003287A2 Compositions and methods for detecting and quantifying circulating tumor cells ctcs
01/05/2012WO2012003279A2 Bioengineered protein pores
01/05/2012WO2012003207A2 Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding pae and pae-like polypeptides
01/05/2012WO2012003129A2 Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
01/05/2012WO2012002887A1 Method and kit for sequential isolation of nucleotide species from a sample
01/05/2012WO2012002775A2 Asthma diagnosis using the neuropilin-1 gene, and method for screening for a therapeutic agent for asthma
01/05/2012WO2012002762A2 Peptide for the treatment or prevention of allergic diseases
01/05/2012WO2012002610A1 Double transgenic sterile oryzias dancena
01/05/2012WO2012002598A1 Primer and probe for diagnosing tuberculosis, a kit comprising the same and a tuberculosis-diagnosing method using the kit
01/05/2012WO2012002597A1 Diagnostic primer for the hepatitis b virus, probe, kit including same, and method for diagnosing the hepatitis b virus using the kit
01/05/2012WO2012002594A1 Diagnostic primer for the hepatitis c virus, probe, kit including same, and method for diagnosing the hepatitis c virus using the kit
01/05/2012WO2012002582A1 Partial region polypeptide of reic/dkk-3 protein
01/05/2012WO2012002562A1 Modified protein therapeutics
01/05/2012WO2012002549A1 Prediction device, prediction method, program, and recording medium
01/05/2012WO2012002541A1 Method for detection of target molecule
01/05/2012WO2012002529A1 Method for determination of risk of behcet's disease
01/05/2012WO2012002507A1 Immunotoxicity evaluation system using multi-color light emitting cell
01/05/2012WO2012002486A1 Method for producing l-amino acid
01/05/2012WO2012002477A1 Highly sensitive mutated gene detection method
01/05/2012WO2012002472A1 Acf detection method
01/05/2012WO2012002460A1 Material for screening for compound capable of acting on ion channel, and use thereof
01/05/2012WO2012002452A1 Gene introduction method
01/05/2012WO2012002450A1 D-succinylase, and method for producing d-amino acid using same
01/05/2012WO2012002447A1 Method for detection of mutated polynucleotide
01/05/2012WO2012002180A1 Method for determination of activity of mitochondrial dna polymerase of plasmodium falciparum malaria, and method for screening for anti-malaria compound
01/05/2012WO2012002087A1 Method for detection of mites belonging to genus acarapis
01/05/2012WO2012002011A1 Method for predicting therapeutic effect of immunotherapy on cancer patient, and gene set and kit to be used in the method
01/05/2012WO2012001976A1 Glucose dehydrogenase
01/05/2012WO2012001941A1 Prophylactic or ameliorating agent for genetic diseases
01/05/2012WO2012001820A1 Psa binding aptamer and method for diagnosis of prostate cancer
01/05/2012WO2012001678A2 Device and methods for treating a lower limb joint pathology and lower limb pain
01/05/2012WO2012001626A1 Novel microrna precursor and use thereof in regulation of target gene expression
01/05/2012WO2012001352A1 Self-deleting plasmid
01/05/2012WO2012001196A2 Alphaviral vectors and the uses thereof for heterologous gene expression
01/05/2012WO2012001170A1 Telomerase reverse transcriptase for protection against ageing
01/05/2012WO2012001169A1 A method for the production of a compound of interest
01/05/2012WO2012001121A1 Calpain-3 inhibitors for treating muscular dystrophies and cardiomyopathies
01/05/2012WO2012001029A1 Gene involved in the development of the seed
01/05/2012WO2012001000A1 Spore surface display of bioactive molecules
01/05/2012WO2012000994A1 Llt-1 antibodies with new functional properties
01/05/2012WO2012000906A1 Blockade of ccl18 signaling via ccr6 as a therapeutic option in fibrotic diseases and cancer
01/05/2012WO2012000890A1 Polypeptide having beta-glucosidase activity and uses thereof
01/05/2012WO2012000889A1 Aptamers that inhibit interaction between antibody and 2nd extracellular loop of human beta-1-adrenergic receptor
01/05/2012WO2012000886A1 Polypeptide having beta-glucosidase activity and uses thereof
01/05/2012WO2012000863A1 Aptamer complex for detecting a diseased tissue
01/05/2012WO2012000861A1 11c-labelled aptamer for detecting a diseased tissue
01/05/2012WO2012000458A1 Telomerase activity inhibiting peptide and manufacturing method and application thereof
01/05/2012WO2012000454A1 Truncated l1 protein of human papillomavirus type 52
01/05/2012WO2012000445A1 New pcr sequencing method and use thereof in hla genotyping
01/05/2012WO2012000443A1 Recombinant tumor vaccine and method of producing such vaccine
01/05/2012WO2012000409A1 Peptides with activity of inhibiting angiogenesis and uses thereof
01/05/2012WO2012000188A1 Recombinant tumor vaccine and method of producing such
01/05/2012WO2012000187A1 Fusion protein of g-csf variant, preparation method and use thereof
01/05/2012WO2012000153A1 High resolution typing method of hla gene based on illumina ga sequencing technology
01/05/2012WO2012000149A1 Dna molecular indexes for high-throughput detecting human papilloma virus
01/05/2012WO2012000094A1 REAGENTS AND METHODS FOR DIAGNOSING CONDITIONS ASSOCIATED WITH HYDROXYLATED HIF 1-α
01/05/2012WO2012000047A1 Soybean nodulation regulatory peptides and methods of use
01/05/2012WO2011143511A3 Methods for producing enteroendocrine cells that make and secrete insulin
01/05/2012WO2011143204A3 Compositions, organisms, systems, and methods for expressing a gene product in plants
01/05/2012WO2011140516A3 Methods for control of flux in metabolic pathways through enzyme relocation
01/05/2012WO2011135141A4 Modified oligonucleotides as regulators of gene expression
01/05/2012WO2011133933A3 Raav-guanylate cyclase compositions and methods for treating leber's congenital amaurosis-1 (lca1)
01/05/2012WO2011133901A3 Aav-based treatment of cholesterol-related disorders
01/05/2012WO2011132854A3 Heterogeneous e. coli for improving fatty acid content using fatty acid biosynthesis and preparation method thereof
01/05/2012WO2011132852A3 Pseudomonas aeruginosa strain developed for improving fatty acid content, and method of manufacturing the same
01/05/2012WO2011130222A3 Compositions and methods comprising variant proteases
01/05/2012WO2011117685A3 Contraceptive peptides derived from spider venom
01/05/2012WO2011116974A3 Adenovirus derived helper virus for enhancing recombinant parvovirus production
01/05/2012WO2011114106A3 Gene silencing
01/05/2012WO2011112089A3 Mutated rep encoding sequences for use in aav production
01/05/2012WO2011112046A3 High molecular weight recombinant silk or silk-like protein, and micro- or nanoscale spider-web fiber or spider-web-like fiber produced using the recombinant silk or silk-like protein
01/05/2012WO2011103467A3 Methods and systems for nucleic acid sequencing validation, calibration and normalization
01/05/2012WO2011103428A3 Production of cellulases and hemicellulases in algal biofuel feedstocks
01/05/2012WO2011103345A3 Methods and compositions for influencing tumors using microrna-185 as a tumor suppressor